{
"NDC": {
"NDCCode": "81607-019-02",
"PackageDescription": "5 SYRINGE, PLASTIC in 1 CARTON (81607-019-02) / 3 mL in 1 SYRINGE, PLASTIC (81607-019-03) ",
"NDC11Code": "81607-0019-02",
"ProductNDC": "81607-019",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Liraglutide",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Liraglutide",
"DosageFormName": "INJECTION, SOLUTION",
"RouteName": "SUBCUTANEOUS",
"StartMarketingDate": "20260226",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA217234",
"LabelerName": "Orbicular Pharmaceutical Technologies Private Limited",
"SubstanceName": "LIRAGLUTIDE",
"StrengthNumber": "6",
"StrengthUnit": "mg/mL",
"Pharm_Classes": "GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-04-17",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260226",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}